(Q43989398)

28 November 2017

title

Simultaneous quantification of sirolimus, everolimus, tacrolimus and cyclosporine by liquid chromatography-mass spectrometry (LC-MS). (English)

1 reference

28 November 2017

1 reference

1 reference

Michael Deters

1

1 reference

28 November 2017

Gabriele Kirchner

series ordinal

2

1 reference

28 November 2017

Klaus Resch

series ordinal

3

1 reference

28 November 2017

Volkhard Kaever

series ordinal

4

1 reference

28 November 2017

publication date

1 March 2002

1 reference

Clinical Chemistry and Laboratory Medicine

28 November 2017

published in

1 reference

28 November 2017

volume

40

1 reference

28 November 2017

issue

3

1 reference

28 November 2017

page(s)

285-292

1 reference

describes a project that uses

28 November 2017

liquid chromatography–mass spectrometry

1 reference

based on heuristic

inferred from title

cites work

Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.045

Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.045

SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.045

The in vivo effect of rapamycin derivative SDZ RAD on lymphocyte proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.045

Combined immunosuppression with cyclosporine (neoral) and SDZ RAD in non-human primate lung transplantation: systematic pharmacokinetic-based trials to improve efficacy and tolerability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.045

Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.045

P-glycoprotein and drug therapy in organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.045

Rapamycin: clinical results and future opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.045

Sirolimus: a new promising immunosuppressive drug. Towards a rationale for its use in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.045

Impact of absorption profiling on efficacy and safety of cyclosporin therapy in transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.045

Cyclosporin metabolism in transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.045

Therapeutic drug monitoring of immunosuppressant drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.045

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.045

21 January 2018

Identifiers

DOI

10.1515/CCLM.2002.045

1 reference

28 November 2017

1 reference